Abstract
Aim
Thyroid transcription factor -1 (TTF1) is a useful immunohistochemical (IHC) marker for diagnosis of primary lung tumours including differential diagnosis between primary lung adenocarcinoma (AdCa) and mesothelioma (MM). Different TTF1 monoclonal antibodies (MoAbs) are available. The clone SP141 achieved the highest score in the 2014 RCPA QAP. Most published studies used the 8G7G3/1 MoAb and inconsistencies in labelling between different antibodies have been described. Our study compared the performance of 8G7G3/1 and SP141 TTF1 MoAbs in primary AdCa and squamous cell carcinoma (SCC) of lung, and MM.
Methods
We examined IHC labelling in 83 cases of MM (17 sarcomatoid, 66 epithelioid), 13 poorly differentiated SCCs and 35 AdCas.
Results
All AdCas labelled with both the SP141 and 8G7G3/1 MoAbs. All MMs and SCCs were negative with 8G7G3/1, but 7/17 sarcomatoid, 0/66 epithelioid MMs and 6/13 SCCs were positive with SP141.
Discussion
TTF1 expression is useful for diagnosis of primary lung AdCas, but different antibodies have different performance profiles, which may have clinical implications and must be taken into account.
Thyroid transcription factor -1 (TTF1) is a useful immunohistochemical (IHC) marker for diagnosis of primary lung tumours including differential diagnosis between primary lung adenocarcinoma (AdCa) and mesothelioma (MM). Different TTF1 monoclonal antibodies (MoAbs) are available. The clone SP141 achieved the highest score in the 2014 RCPA QAP. Most published studies used the 8G7G3/1 MoAb and inconsistencies in labelling between different antibodies have been described. Our study compared the performance of 8G7G3/1 and SP141 TTF1 MoAbs in primary AdCa and squamous cell carcinoma (SCC) of lung, and MM.
Methods
We examined IHC labelling in 83 cases of MM (17 sarcomatoid, 66 epithelioid), 13 poorly differentiated SCCs and 35 AdCas.
Results
All AdCas labelled with both the SP141 and 8G7G3/1 MoAbs. All MMs and SCCs were negative with 8G7G3/1, but 7/17 sarcomatoid, 0/66 epithelioid MMs and 6/13 SCCs were positive with SP141.
Discussion
TTF1 expression is useful for diagnosis of primary lung AdCas, but different antibodies have different performance profiles, which may have clinical implications and must be taken into account.
| Original language | English |
|---|---|
| Pages (from-to) | S76-S77 |
| Number of pages | 2 |
| Journal | Pathology |
| Volume | 47 |
| Issue number | Supp. 1 |
| DOIs | |
| Publication status | Published - 2015 |
| Event | 39th Annual Scientific Meeting of the Australasian Division of the International Academy of Pathology - Brisbane Convention & Exhibition Centre, Brisbane, Australia Duration: 30 May 2014 → 1 Jun 2014 |
Keywords
- TTF1 antibodies
- immunohistochemical (IHC) marker
- differential diagnosis